What is the dosage of Baxdela?

Baxdela is available in 2 dosages, including 300 mg Injection and 450 mg Tab

What does Baxdela treat?

Baxdela treats Escherichia coli Infections, Klebsiella Infections, Pseudomonas Infections, Staphylococcal Infections, Streptococcal Infections and Bacterial Skin Diseases

What is Baxdela made of?

Baxdela contains delafloxacin which is a Fluoroquinolone Antibacterial

How is Baxdela administered?

Baxdela is administered as a Injectable or Oral Pill

Dosage & Administration Drug label Prior authorization Financial assistance

Patient education

Baxdela

(delafloxacin)

delafloxacin 300 MG Injection [Baxdela]delafloxacin 450 MG Oral Tablet [Baxdela]

BLACK BOX WARNING

Dosage & administration

* For ABSSSI and CABP: Administer BAXDELA for injection 300 mg by intravenous infusion over 60 minutes, every 12 hours, or a 450 mg BAXDELA tablet orally every 12 hours.
* Recommended duration of treatment:
* ABSSSI: 5 to 14 days
* CABP: 5 to 10 days

* Dosage for patients with renal impairment is based on the estimated glomerular filtration rate (eGFR)

Estimated Glomerular Filtration Rate (eGFR)(mL/min/1.73m2) *	Recommended Dosage Regimen for BAXDELA †
* Estimate of GFR based on a Modification of Diet in Renal Disease (MDRD) equation. * For a total treatment duration of 5 to 14 days for the treatment of ABSSSI and 5 to 10 days for the treatment of CABP. * All intravenous doses of BAXDELA are administered over 60 minutes. * Not recommended due to insufficient information to provide dosing recommendations.
	Oral	Intravenous ‡
30-89	No dosage adjustment	No dosage adjustment
15-29	No dosage adjustment	200 mg every 12 hours
End Stage Renal Disease (ESRD) (< 15 including hemodialysis)	Not Recommended §

drug label

Baxdela prescribing information

Have more Baxdela questions?

Submit MSL Request

Learn More

Need to report a Baxdela issue?

ONLINE FORMReport adverse event

Learn More

prior authorization

Baxdela Prior authorization resources

NOT PROVIDED BY BRANDComplete Letter of Medical Necessity

NOT PROVIDED BY BRANDCoverage Authorization Request

NOT PROVIDED BY BRANDCoverage Authorization Appeals

Learn More

Benefits investigation

NOT PROVIDED BY BRANDBenefits investigation resources

Learn More

Reimbursement help (FRM)

NOT PROVIDED BY BRANDReimbursement help (FRM) resources

Learn More

financial assistance

Baxdela Financial assistance options

Co-pay savings program

commercial only

NOT PROVIDED BY BRANDEnroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Baxdela Patient education

Getting started on Baxdela

NOT PROVIDED BY BRANDInstructions For Use: ABSSSI

NOT PROVIDED BY BRANDInstructions For Use: CABG (Community Acquired Bacterial Pneumonia)

Patient toolkit

NOT PROVIDED BY BRANDNot Provided By Brand

Learn More

Can't find what you're looking for?

Our trained staff can help you:

Please note:

Access to a Field Reimbursement Manager (FRM) or Medical Science Liaison (MSL) varies by brand and may require talking with your rep first.
Samples are provided at the discretion of the brand.
We are unable to collect Protected Health Information (PHI), fill out forms, or submit them on your behalf.